Search research articles
Contact Us
Filters
Showing results (61-70 of 118) with videos related to
Page
of 12
Sort By:
Plos One
|
November 13, 2010
PPARγ downregulation by TGFß in fibroblast and impaired expression and function in systemic sclerosis: a novel mechanism for progressive fibrogenesis
Jun Wei, Asish K Ghosh, Jennifer L Sargent, et al.
Arthritis and Rheumatism
|
February 14, 2012
Wnt/β-catenin signaling is hyperactivated in systemic sclerosis and induces Smad-dependent fibrotic responses in mesenchymal cells
Jun Wei, Feng Fang, Anna P Lam, et al.
Arthritis Research & Therapy
|
August 19, 2015
Nilotinib (Tasigna™) in the treatment of early diffuse systemic sclerosis: an open-label, pilot clinical trial
Jessica K Gordon, Viktor Martyanov, Cynthia Magro, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
December 16, 2014
Myofibroblasts in murine cutaneous fibrosis originate from adiponectin-positive intradermal progenitors
Roberta Goncalves Marangoni, Benjamin D Korman, Jun Wei, et al.
Arthritis and Rheumatism
|
February 13, 2013
Increased expression of endoplasmic reticulum stress and unfolded protein response genes in peripheral blood mononuclear cells from patients with limited cutaneous systemic sclerosis and pulmonary arterial hypertension
Stefania Lenna, Alessandra G Farina, Viktor Martyanov, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology
|
December 21, 2018
Lysyl oxidase enzymes mediate TGF-β1-induced fibrotic phenotypes in human skin-like tissues
Mengqi Huang, Zhiyi Liu, Lauren Baugh, et al.
Arthritis Research & Therapy
|
June 14, 2015
Gene expression changes reflect clinical response in a placebo-controlled randomized trial of abatacept in patients with diffuse cutaneous systemic sclerosis
Eliza F Chakravarty, Viktor Martyanov, David Fiorentino, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
October 27, 2017
Belimumab for the Treatment of Early Diffuse Systemic Sclerosis: Results of a Randomized, Double-Blind, Placebo-Controlled, Pilot Trial
Jessica K Gordon, Viktor Martyanov, Jennifer M Franks, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
October 8, 2003
Systemic and cell type-specific gene expression patterns in scleroderma skin
Michael L Whitfield, Deborah R Finlay, John Isaac Murray, et al.
Tissue Engineering. Part C, Methods
|
July 21, 2025
T Cells Enhance Tissue Complexity and Function to Study Fibrosis in 3D Skin-Like Tissue Models
Isha Singh, Madeline Morrisson, Sasha Shenk, et al.
Page
of 12
Search research articles
Search
Showing results (61-70 of 118) with videos related to
Sort By:
Page
of 12
Plos One
|
November 13, 2010
PPARγ downregulation by TGFß in fibroblast and impaired expression and function in systemic sclerosis: a novel mechanism for progressive fibrogenesis
Jun Wei, Asish K Ghosh, Jennifer L Sargent, et al.
Arthritis and Rheumatism
|
February 14, 2012
Wnt/β-catenin signaling is hyperactivated in systemic sclerosis and induces Smad-dependent fibrotic responses in mesenchymal cells
Jun Wei, Feng Fang, Anna P Lam, et al.
Arthritis Research & Therapy
|
August 19, 2015
Nilotinib (Tasigna™) in the treatment of early diffuse systemic sclerosis: an open-label, pilot clinical trial
Jessica K Gordon, Viktor Martyanov, Cynthia Magro, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
December 16, 2014
Myofibroblasts in murine cutaneous fibrosis originate from adiponectin-positive intradermal progenitors
Roberta Goncalves Marangoni, Benjamin D Korman, Jun Wei, et al.
Arthritis and Rheumatism
|
February 13, 2013
Increased expression of endoplasmic reticulum stress and unfolded protein response genes in peripheral blood mononuclear cells from patients with limited cutaneous systemic sclerosis and pulmonary arterial hypertension
Stefania Lenna, Alessandra G Farina, Viktor Martyanov, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology
|
December 21, 2018
Lysyl oxidase enzymes mediate TGF-β1-induced fibrotic phenotypes in human skin-like tissues
Mengqi Huang, Zhiyi Liu, Lauren Baugh, et al.
Arthritis Research & Therapy
|
June 14, 2015
Gene expression changes reflect clinical response in a placebo-controlled randomized trial of abatacept in patients with diffuse cutaneous systemic sclerosis
Eliza F Chakravarty, Viktor Martyanov, David Fiorentino, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
October 27, 2017
Belimumab for the Treatment of Early Diffuse Systemic Sclerosis: Results of a Randomized, Double-Blind, Placebo-Controlled, Pilot Trial
Jessica K Gordon, Viktor Martyanov, Jennifer M Franks, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
October 8, 2003
Systemic and cell type-specific gene expression patterns in scleroderma skin
Michael L Whitfield, Deborah R Finlay, John Isaac Murray, et al.
Tissue Engineering. Part C, Methods
|
July 21, 2025
T Cells Enhance Tissue Complexity and Function to Study Fibrosis in 3D Skin-Like Tissue Models
Isha Singh, Madeline Morrisson, Sasha Shenk, et al.
Page
of 12